AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$49.9K
This Quarter Return
-44.86%
1 Year Return
+0.25%
3 Year Return
-18.22%
5 Year Return
–
10 Year Return
–
AUM
$1.34M
AUM Growth
+$1.34M
(-8.1%)
Cap. Flow
+$738K
Cap. Flow
% of AUM
54.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Castle Biosciences
CSTL
|
$738K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Castle Biosciences
CSTL
$690M
| $738K | 54.91% |
+33,626
| New | +$738K |
|
|
WHWK
2
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$83.4M
| $329K | 24.48% |
26,666
| – | – |
|
3
Synlogic
SYBX
$16.8M
| $237K | 17.63% |
205,906
| – | – |
|
|
ACGN
4
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $26K | 1.93% |
56,250
| – | – |
|
|
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $8K | 0.6% |
45,849
| – | – |
|
|
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
| $6K | 0.45% |
375,000
| – | – |
|